Skip to main content
. Author manuscript; available in PMC: 2017 Dec 6.
Published in final edited form as: Int J Hematol. 2011 Jan 19;93(2):206–212. doi: 10.1007/s12185-010-0747-x

Table 2.

Comparison of donor chimerism at days 30 and 90 post-transplant for t-IV Bu/Flu + rituximab versus t-IV Bu/Flu

t-IV Bu/Flu + rituximab t-IV Bu/Flu p value
Day 30 (CD3) 100% (10–100%) 93% (75–100%) 0.9
Day 30 (CD33) 100% (79–100%) 100% (61–100%) 0.86
Day 30 (unsorted BM) 98% (84–100%) 98% (45–100%) 0.54
Day 90 (CD3) 94% (73–100%) 90% (62–100%) 0.25
Day 90 (CD33) 100% 100% (90–100%) 0.35
Day 90 (unsorted BM) 95% (88–100%) 98% (93–100%) 0.25